Concepedia

Richard N. Channick

RN

Statistics

Publications

110

Citations

15.8K

H-Index

58

Active since

1993

Affiliations

University of California San Diego(Current)

Massachusetts General Hospital

Actelion (Switzerland)

The University of Texas Southwestern Medical Center

University of California, Los Angeles

Richard N. Channick is an author at University of California San Diego specializing in pulmonary hypertension, medicine, and pulmonology.

ORCID

Publications per year

1993–2025

110

Publications

110

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study

Richard N. Channick, G Simonneau, Olivier Sitbon et al. · The Lancet · 2001 · 1.5K citations

, , +13

Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension

Tomás Pulido, Igor Adzerikho, Richard N. Channick et al. · New England Journal of Medicine · 2013 · 1.4K citations · Full text

, , +13

Selexipag for the Treatment of Pulmonary Arterial Hypertension

Olivier Sitbon, Richard N. Channick, Kelly Chin et al. · New England Journal of Medicine · 2015 · 1.1K citations · Full text

, , +14

Pulmonary endarterectomy: experience and lessons learned in 1,500 cases

Stuart W. Jamieson, David P. Kapelanski, Naohide Sakakibara et al. · The Annals of Thoracic Surgery · 2003 · 768 citations

, , +9

Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2

Marc Humbert, Robyn J. Barst, Ivan M. Robbins et al. · European Respiratory Journal · 2004 · 641 citations · Full text

, , +12

1–5 of 110